Fig. 8From: Reducing the effective dose of cisplatin using cobalt modified silver nano-hybrid as a carriers on MCF7 and HCT cell modelstoxicity test at different concentrations (µg/ml) of Cis, CoAg, and CoAg@Cis on (a) MCF-7 (b) HCT cell linesBack to article page